Dr Reddy's launch antibiotic drug in US
New Delhi, March 5, 2014: The Indian drug major Dr Reddy’s Laboratories Ltd has launched Moxifloxacin Hydrochloride tablets in the US market. The tablets are used for the treatment of a wide range of diseases, including pneumonia, bronchitis and skin infections.
The drug was launched by the Indian drug firm after receiving approval from the US Food & Drug Administration (USFDA).
The tablets are a generic version of Avelox 400 mg and are available in bottle counts of 30. As per the data from IMS Health, the Avelox tablets registered sales worth US$ 195 million in 2013.